Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available
Langston, Anne L, Johnston, Marie, Francis, Jill, Robertson, Clare, Campbell, Marion K, Entwistle, Vikki A, Marteau, Theresa, Maclennan, Graeme, Weinman, John, McCallum, Marilyn, Miedzybrodska, Zosia, Charnock, Keith, Ralston, Stuart H
Published in BMC health services research (29.05.2008)
Published in BMC health services research (29.05.2008)
Get full text
Journal Article
Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone
Cronin, Owen, Forsyth, Laura, Goodman, Kirsteen, Lewis, Steff C, Keerie, Catriona, Walker, Allan, Porteous, Mary, Cetnarskyj, Roseanne, Ranganath, Lakshminarayan R, Selby, Peter L, Hampson, Geeta, Chandra, Rama, Ho, Shu, Tobias, Jon H, Young-Min, Steven, McKenna, Malachi J, Crowley, Rachel K, Fraser, William D, Gennari, Luigi, Nuti, Ranuccio, Brandi, Maria Luisa, Del Pino-Montes, Javier, Devogelaer, Jean-Pierre, Durnez, Anne, Isaia, Giancarlo, Di Stefano, Marco, Guañabens, Núria, Blanch, Josep, Seibel, Markus J, Walsh, John P, Kotowicz, Mark A, Nicholson, Geoffrey C, Duncan, Emma L, Major, Gabor, Horne, Anne, Gilchrist, Nigel L, Boers, Maarten, Murray, Gordon D, Charnock, Keith, Wilkinson, Diana, Russell, R Graham G, Ralston, Stuart H
Published in BMJ open (01.09.2019)
Published in BMJ open (01.09.2019)
Get full text
Journal Article